Galenica continues to establish itself as a pioneer of integrated healthcare
Dear Shareholders, Ladies and Gentlemen,
We can look back on a successful first half of the year. In the first half of 2025, we once again achieved strong sales growth of 5.0%. In addition to a significant increase in profitability, we also achieved significant improvements in cash flow in the first half of the year.
As Switzerland’s leading healthcare network, Galenica is consistently pursuing its growth strategy in the first half of 2025 and is recording positive developments in all segments. With a broad range of integrated solutions and a strong focus on the needs of our patients and customers, we are shaping the future of healthcare. We have further strengthened our market position, developed innovative services and implemented efficiency improvements. Furthermore, we have announced our entry into the diagnostics business.
Pharmacy services continue to gain importance
In the first half of 2025, the Galenica network grew by a net total of five pharmacies to 381 locations and further expanded its presence in all language regions of Switzerland. A special milestone was reached with the opening of the 200th Amavita pharmacy in Morbio Inferiore. Galenica focuses on sound pharmaceutical advice and the “Consultation plus” initiative. Demand for consultation and healthcare services in pharmacies has continued to rise – both for acute problems and in the area of preventive health checks or vaccinations. With OneDoc, customers can now book appointments online at over 90% of Galenica pharmacies.
It is encouraging that Parliament passed the second cost containment package in March 2025, which further strengthens and recognises the competencies of pharmacies. In future, additional preventive and interprofessional services in pharmacies will be reimbursed directly by basic insurance.
Prescription Manager launched as a digital assistant
With the launch of the Prescription Manager in February 2025, we are offering our customers and patients another innovative omni-channel solution. This makes it possible to manage repeat prescriptions online and re-order medications digitally – for home delivery or collection from a selected pharmacy. More than 10,000 people are already using the service, and the number is growing steadily. The digital assistant provides valuable support, especially to people with chronic illnesses, who require medication on a regular basis.
More patient safety thanks to digital solutions
Patient safety is and remains one of our most important objectives, and HCI Solutions is one of the key drivers in this area. For example, HCI Solutions supported the professional associations FMH and pharmaSuisse as a partner of expertise in the launch of the e-prescription. Around 6,000 e-prescriptions are already being issued via Documedis every month. Clinical Decision Support (CDS) checks, which enable healthcare professionals to check patients’ medication, also contribute to patient safety. Since the beginning of the year, over 240 million CDS checks have been carried out on Documedis.
ERP migration at Lausanne-Ecublens, increase in efficiency at Alloga
The “Wholesale” sector grew in both the pharmacy business and the wholesale business with doctors in the first six months of the year. In March 2025, the major migration of the ERP system at the Lausanne-Ecublens site was also completed. The focus in the second half of the year is now on continuously increasing efficiency and supplying customers in French-speaking Switzerland entirely from the Lausanne-Ecublens site.
Pre-wholesale specialist Alloga converted its ERP system back in 2024, which improved efficiency in the first half of 2025.
„The diagnostic service provider Labor Team is an excellent strategic and cultural fit for Galenica.“
Galenica enters the diagnostics business
In July 2025, we announced the acquisition of the Labor Team Group. Galenica is thus gaining a leading Swiss diagnostic service provider for its healthcare network. The acquisition strengthens our offering in the doctor's segment and opens up long-term potential for additional pharmacy services in the field of diagnostics. The transaction is subject to approval by the Swiss Competition Commission (COMCO) and is expected to be completed in the second half of 2025. Labor Team is an excellent strategic and cultural fit for Galenica – together we want to drive innovation in healthcare.
New member of the Board of Directors and change in the position of General Counsel
With the election of Nadine Balkanyi-Nordmann to the Board of Directors, Galenica has gained a leading expert in the financial services and healthcare sector. A change in the extended Executive Committee has been announced in the position of General Counsel and in the General Secretariat. Barbara Wälchli, who currently holds both roles, is leaving the company at the end of 2025 to take on a new challenge. Her current deputy, Cécile Matter, will take over as General Counsel on 1 November 2025. Jürg Pauli, who is responsible for Sustainability, Public Affairs & Transformation, will also take over the General Secretariat of the Board of Directors.
Continuous improvement established as a key principle
A key element of the Galenica strategy is the ongoing improvement of efficiency in all business sectors. The continuous improvement of processes at the initiative of all employees is a key principle that has now been established, from logistics and pharmacies to all support functions. Through our corporate culture, we promote active participation, personal responsibility and servant leadership. In this way, we are constantly becoming more efficient and innovative and increasing our attractiveness as an employer.
In conclusion, after the first half of 2025, we can say that, thanks to a sustainable strategy and a unique business model, we are continuing to play a leading role in the Swiss healthcare market. With Galenica shares performing very well in the first half of 2025, this was also rewarded on the capital market.
In this half year report, we are delighted to present details of Galenica’s continued positive development. And we would like to thank you, our valued shareholders, for the trust you have placed in us. We would also like to thank our partners and customers, who trust us with their health and well-being every day. And finally, we would like to thank our employees, for their daily commitment to health and well-being in Switzerland.
Bern, 7 August 2025
Dr Markus R. Neuhaus
Chair of the Board of Directors
Marc Werner
CEO